The facility is expected to produce 500 million vaccine doses annually
Kenya has signed a deal with US biotechnology company, Moderna Inc, to build a vaccine manufacturing facility in the country.
The facility if expected to produce up to 500 million doses of vaccines annually.
The deal has been hailed as one that will help solve vaccine access in the current coronavirus pandemic and in future pandemics.
Moderna anticipates to invest more than $500m (£380m) in the facility.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Latest Stories
-
CAF Confederation Cup: Dreams face Zamalek, RS Berkane take on holders, USM Algiers
2 hours -
PURC could have found a better approach to settle issues with ECG – Dr Manteaw
2 hours -
CAFCC: John Antwi sure of positive result against Zamalek
3 hours -
I’ll choose Osofo Kyiri Abosom as my running mate over Akua Donkor – Prophet Kumchacha
3 hours -
LPG prices surge in Ghana, raising concerns over tax impact
3 hours -
I commend PURC for taking courageous step to fine ECG board members – Kwame Pianim
3 hours -
Financing assurance secured from bilateral creditors to aid 2nd review funding for Ghana – IMF Africa head
4 hours -
Man who set himself on fire outside Trump’s Manhattan hush money trial dies
4 hours -
Fuel purchase issues have nothing to do with personal interest – Egypa Mercer
4 hours -
ISRQ2024: Theorose School wins Championship with 0.5 points, heads to Canada
4 hours -
Use your voice, talents, skills to advocate for positive change – UniMAC VC tells graduates
4 hours -
Livestream: Newsfile discusses ‘dumsor’, Ex-MASLOC CEO jail and Election 2024
5 hours -
Otumfuo STEM Festival launched to find problem-solvers, promote science education
5 hours -
Irene Logan ties the knot in colourful ceremony
5 hours -
Alliance with other parties, not a merger – Alan Kyerematen
5 hours